ALTS vs MRT

ALTS exhibits severe financial distress signals, with a Piotroski F-Score of 2/9 indicating poor operational and financial health. The company's Altman Z-Score is unavailable, but its negative ROA (-1.71%), negative operating margin (-218.34%), and extremely low current ratio (0.80) suggest high bankruptcy risk. Despite strong revenue growth (53.3% YoY), profitability remains elusive, and the stock trades at a steep Price/Sales of 6.85, far above its low Price/Book of 0.11. The 52-week price range ($1.08–$10.95) and 5-year decline of 82.8% reflect deep investor skepticism, despite a single 'strong_buy' analyst recommendation.

MRT exhibits critical financial instability, highlighted by a weak Piotroski F-Score of 3/9 and a negative Price-to-Book ratio of -2.18, indicating negative shareholder equity. While the company shows explosive revenue growth of 143.10% and maintains a strong gross margin of 61.29%, these are offset by severe net losses (-105.62% profit margin) and poor liquidity (Current Ratio 0.97). There is a stark divergence between the 'Strong Buy' analyst consensus and the bearish technical trend (0/100) and deteriorating long-term price performance. The company is currently in a high-risk speculative phase where growth is not yet translating into financial viability.